The UL4 gene is conserved within the genome of defective interfering particles of equine herpesvirus type 1 (EHV-1) that mediate persistent infection. Here, we show that the UL4 protein inhibits EHV-1 reporter gene expression by decreasing the level of transcribed mRNA. The UL4 protein did not bind any gene class of EHV-1 promoters in electromobility or chromatin immunoprecipitation assays, but directly interacted with the TATA box-binding protein (TBP) and the carboxy-terminal domain of RNA polymerase II both in vitro (GST-pulldown assays) and in infected cells (coimmunoprecipitation analyses). Microarray analyses of the expression of the 78 EHV-1 genes revealed that viral late genes important for virion assembly displayed enhanced expression in cells infected with UL4-null virus as compared to wild-type or UL4-restored EHV-1. Quantitative PCR analyses showed that viral DNA replication was not retarded in cells infected with the UL4-null virus as compared to wild-type EHV-1.
Introduction
The Alphaherpesvirinae subfamily member equine herpesvirus 1 (EHV-1) is a significant etiologic agent of severe respiratory, neurological, and abortigenic disease in equines worldwide (Allen and Bryans, 1986; O'Callaghan and Osterrieder, 2008) . The viral gene program is expressed in a coordinated and temporal fashion, such that the 78 EHV-1 genes (Telford et al., 1992) are expressed at immediate-early (IE), early (E), and late (L) stages of infection (Caughman et al., 1985; Gray et al., 1987) . Extensive work has been completed to describe the EHV-1 proteins responsible for controlling the expression of viral genes. The majority of the regulatory proteins are activators of viral gene expression. The essential IE gene encodes the sole IE protein (IEP) that is the major trans-activator of early and some late genes Caughman et al., 1988; Garko-Buczynski et al., 1998; Grundy et al., 1989; Smith et al., 1992 Smith et al., , 1994 . The IEP also functions to trans-repress its own gene expression (Smith et al., 1992) . Early regulatory proteins IR4P and UL5P function in a synergistic manner with the IEP to mediate the full activation of early and late EHV-1 gene promoters (Albrecht et al., 2004; Holden et al., 1995; Kim et al., 1997; Zhao et al., 1995) . The powerful and promiscuous EICP0P can independently activate expression of all three gene classes and is capable of antagonizing the transactivation potential of the IEP (Bowles et al., 1997 (Bowles et al., , 2000 . The late equine α-trans-inducing factor (ETIF) is a tegument protein required for secondary envelopment and virus egress as well as the activation of expression of the IE gene promoter (Kim and O'Callaghan, 2001; Lewis et al., 1993; Purewal et al., 1994; von Einem et al., 2006) . The early IR2 protein and the IR3 transcript serve to inhibit EHV-1 gene expression (Ahn et al., 2010; Kim et al., 2006 Kim et al., , 2011 . The IR2P is a major inhibitory protein and is a truncated version of the IEP (Harty and O'Callaghan, 1991; Kim et al., 2006 Kim et al., , 2011 . Finally, the IR3 gene is unique to EHV-1 (Holden et al., 1992) , lies antisense to the IE transcript, does not produce a translated protein, and plays a role in down-regulating IE gene expression (Ahn et al., 2007 (Ahn et al., , 2010 .
Serial, high multiplicity passage of EHV-1 in cell culture or Syrian hamsters results in the production of defective interfering particles (DIP) that are capable of interfering with standard viral replication and establishing a state of persistent infection (Campbell et al., 1976; Chen et al., 1996 Chen et al., , 1999 Dauenhauer et al., 1982; Ebner et al., 2008; Ebner and O'Callaghan, 2006; Henry Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/yviro et al., 1979) . The DIP genome ( $7.5 kbp) is a severely truncated and rearranged form of the standard viral genome ( $ 155 kbp) and consists of only three genes: the perfectly conserved UL3 and UL4 genes and a hybrid gene that is comprised of portions of the IR4 and UL5 regulatory genes, which is important for the interference with standard viral replication (Chen et al., 1996 (Chen et al., , 1999 Ebner et al., 2008; Ebner and O'Callaghan, 2006) . Until recently, no functional role for the UL3 and UL4 proteins had been described. It was reported that the UL4 protein was capable of inhibiting gene expression in transient transfection assays, and cells infected with EHV-1 lacking expression of the UL4 protein exhibited increased levels of viral gene transcripts during lytic infection (Charvat et al., 2011) . Additionally, an EHV-1 lacking the complete UL4 openreading frame (ORF) was incapable of producing the DIP genome after serial, undiluted passage, while a mutant EHV-1 that possessed the UL4 ORF but did not express the UL4 protein was still capable of generating the DIP genome (Charvat et al., 2012) . In the present study, we elaborate on the properties of the UL4 protein and begin to characterize its mechanism of inhibition. Expression of the UL4 protein decreased reporter gene transcript levels, possibly through direct interactions with the TATA boxbinding protein (TBP) and the carboxy-terminal domain of RNA polymerase II. The UL4 protein is not a DNA-binding protein as it fails to interact with EHV-1 promoters in gel shift assays and does not associate with EHV-1 promoters in chromatin immunoprecipitation assays. Microarray analysis of the expression of all 78 EHV-1 genes in cells infected with wild-type or ΔUL4 EHV-1 revealed that late gene expression is enhanced in the absence of the UL4 gene. Quantitative PCR analyses showed that viral DNA synthesis was not retarded in cells infected with ΔUL4 EHV-1 as compared to cells infected with wild type EHV-1.
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Results
Expression of the UL4P decreases messenger RNA levels
In our previous publication (Charvat et al., 2011) , we demonstrated that the UL4 protein was capable of inhibiting luciferase gene expression driven by various EHV-1 promoters, and experiments using the chloramphenicol acetyltransferase (CAT) reporter system validated these original findings (data not shown). Previous data indicated that the absence of UL4 protein synthesis during infection with a mutant UL4 EHV-1 resulted in elevated levels of viral transcripts (Charvat et al., 2011) . These data suggested that the UL4P may be responsible for affecting mRNA levels; specifically, it may play a role in reducing transcripts. To assess whether expression of the UL4 protein reduces transcript levels, two groups of RK13 cells were transiently transfected with the gK-Luc reporter plasmid, along with expression plasmids for the EICP0 and UL4 proteins. The EICP0 protein has been shown to activate the gK promoter (Bowles et al., 1997; Kim et al., 1999) ; thus, it serves as a positive control for a protein that increases gene expression. One group of transfected cells was used to determine mRNA levels by harvesting RNA at 4 h post-transfection (hpt) and performing a northern blot for the luciferase transcript (Fig. 1) . The other group of cells was used to perform a luciferase assay (48 hpt) to correlate mRNA levels with luciferase activity (Fig. 1A) . As expected, expression of the EICP0 protein increased the luciferase activity driven by the gK promoter, which was approximately twofold greater than gK-Luc activity alone. Additionally, the increase in luciferase activity corresponded to a 78% increase in mRNA levels (Fig. 1B) . Conversely, expression of the UL4 protein decreased the amount of luciferase activity by 50%, which coincided with diminished amounts of the luciferase transcript which were approximately 46% of the levels of the gK-Luc transcript alone. Thus, the decreased luciferase activity correlated to decreased mRNA levels. These findings indicate that inhibition of gene expression by the UL4 protein is mediated at the level of transcription.
Decreased transcript levels are not a result of mRNA instability After observing that the gK-Luc transcript was decreased in the presence of the UL4 protein, we examined mRNA stability as an explanation for reduced transcript levels. It is possible that the UL4 protein plays a role in increasing mRNA turnover or decreasing the stability of transcripts. To assess whether the UL4 protein was involved in mRNA stability, we utilized quantitative real-time PCR (qRT-PCR) to examine the half-life of mRNA from cells infected with either wild-type or ΔUL4 EHV-1. Rabbit kidney RK13 cells were infected at a multiplicity of 5 with each virus and incubated for 12 h in normal medium. After 12 h of infection, the medium was replaced with medium supplemented with 1 μM Actinomycin D (Act D) to prevent any further transcription. RNA samples were collected every 3 h for a total of 18 h and the levels of the late glycoprotein 2 (gp2) transcript were determined by qRT-PCR. The results are summarized in Table 1 and revealed that the overall levels of the gp2 transcript are not greatly altered during the course of the Act D treatment, suggesting that the gp2 mRNA is inherently stable. Furthermore, the presence of the UL4 protein had no effect on the stability of the gp2 mRNA as indicated by similar levels of message at both 3 and 18 h post-Act D treatment. These observations were reproducible in multiple experiments and revealed that the UL4 protein is not responsible for increasing mRNA instability and turnover, but rather it is likely involved in the process of gene transcription. that the UL4P binds to DNA in such a way to block transcription from the targeted genes. This potential DNA-binding activity could affect the assembly of the pre-initiation complex (PIC) involved in the transcription of viral genes, as is observed with the EHV-1 IR2 protein (Kim et al., 2006 (Kim et al., , 2011 and the IE2 (IE86) protein of human cytomegalovirus (Lee et al., 1996; Wu et al., 1993) . Inhibition of viral transcription through DNA binding is also documented for human papillomaviruses, where the E1M\widehatE2C fusion protein inhibits viral gene expression as an E2-binding sitespecific repressor (Chiang et al., 1991) . Therefore, the ability of the UL4 protein to bind DNA was explored. Electromobility shift assays (EMSA) were utilized to determine whether a recombinant GST-UL4 fusion protein possessed DNA-binding activity for the IE, TK, IR4, and UL5 gene promoters, all of which were shown to be inhibited by the UL4P in reporter assays (Charvat et al., 2011; unpublished observation) . The GST protein alone was used as a negative control; while the GST-IR2 fusion protein that has documented DNA-binding properties (Kim et al., 1995) was used as a positive control. As expected, the GST protein was unable to bind any of the four radiolabeled promoters (Fig. 2 , lanes A1, B1, C1, and D1). In contrast, the GST-IR2 fusion protein readily bound to the four EHV-1 promoters (Fig. 2 , lanes A2, B2, C2, and D2), which was confirmed by a shift in the mobility of the radiolabeled DNA-protein complexes using anti-IR2P monoclonal antibody A1.4 (Fig. 2 , lanes A4, B3, C3, and D3). As expected, pre-immune serum (Fig. 2, lane 3) or antibody to the EHV-1 TAD (Fig. 2 , lanes A5 and B4) failed to cause a supershift in the DNA-protein complexes. However, no DNA-binding activity was observed for the GST-UL4 fusion protein with the IE, TK, IR4, or UL5 promoters over a range of protein concentrations (Fig. 2 , lanes A6-A8, B5-B7, C4-C6, and D4-D6). Very minor bands were not reproducibly detected and were considered as background.
To confirm that the UL4 protein is not a DNA-binding protein, chromatin immunoprecipitation (ChIP) assays were carried out. EHV-1-infected HeLa cells were crosslinked with 1% formaldehyde, cell pellets were lyzed, and lysates were treated with micrococcal nuclease. Immunoprecipitation was performed overnight in spin columns using pre-immune serum, anti-RNA polymerase II antibody, or anti-UL4 antibody. DNAs were eluted and recovered, and PCR assays were carried out to amplify precipitated target sequences. As shown in Fig. 3 , RNA polymerase II as the positive control was readily detected and associated with the EHV-1 UL4 promoter. In contrast, antibody to the UL4 protein failed to reveal an association of this EHV-1 protein with the UL4 promoter or with the immediate-early, early TK, or late gK promoters (Fig. 3 ). Similar findings were obtained at both early (6 h) and late times (10 h and 16 h) after infection and indicate that the UL4 protein is not directly associated with viral DNA sequences and suggest that the inhibition of EHV-1 gene expression by UL4P is not mediated through its binding to promoter DNA sequences.
The UL4P directly interacts with TBP and RNA polymerase II
Whether the UL4 protein interacts with cellular transcription factors to inhibit gene expression was examined as a possible mechanism for decreased transcription. Initial experiments were carried out with general transcription factors (GTFs) involved in the assembly of the pre-initiation complex (PIC) at gene promoters (Buratowski et al., 1989; Davison et al., 1983; Kornberg, 2007; Van Dyke et al., 1988) . The TFIID complex, which includes the TATA box-binding protein (TBP), plays a critical role in initiating PIC assembly and transcription and is a target for a number of viral proteins including the E1A protein of adenovirus (Geisberg et al., 1995) , the ICP4 protein of herpes simplex virus 1 (Lester and DeLuca, 2011) , as well as the EHV-1 IE, IR2, EICP0, and UL5 proteins (Albrecht et al., 2004; Kim et al., 2003 Kim et al., , 2006 Kim et al., , 2011 .
Direct protein-protein interactions were assessed using in vitro GST-pulldown assays with the GST-UL4 fusion protein and purified cellular transcription factors TFIIA, TFIIB, TBP and RNA polymerase II (Pol II). Again, the GST protein and GST-IR2 fusion protein were used as negative and positive controls, respectively. Expectedly, the GST protein alone did not interact with any of the cellular GTFs (Fig. 4 , lanes A3 and B3). When purified TBP was incubated with GST-IR2, a direct interaction was observed (Fig. 4A , lane 4). TBP was also found to bind to the GST-UL4 fusion protein (Fig. 4A , lane 5). Similar results were obtained when the GST-IR2 and GST-UL4 fusion proteins were incubated with purified samples of the carboxy-terminal domain (CTD) of Pol II, as shown in Fig. 4B , lanes 4 and 5. However, no interaction was observed between GST-UL4 and TFIIA, TFIIB, or the EHV-1 IEP (Fig. 5 ). These findings indicate that the UL4 protein directly interacts with TBP and the CTD of Pol II, observations that suggest that the UL4 protein may prevent the assembly of a pre-initiation complex at viral promoters to inhibit gene expression.
The UL4 protein partners with TBP and pol II during EHV-1 infection
It was demonstrated that the UL4P directly interacts with TBP and RNA polymerase II (Pol II) in vitro through GST-pulldown assays (Fig. 4) . However, as this is an artificial system to examine protein-protein interactions, we next addressed whether this interaction occurred during viral infection. HeLa cells were mock infected or infected with the wild-type RacL11 strain of EHV-1. Co-immunoprecipitation assays were performed using the UL4-specific OC95 antibody (Charvat et al., 2011) or a non-related antibody to EHV-1 glycoprotein D (gD). The immunoprecipitated complexes were subjected to SDS-PAGE and western blot analysis using antibodies specific for TBP or Pol II (Fig. 6) . Immunoprecipitation with the anti-UL4P antibody of mock infected cell extracts yielded no interaction with either TBP or Pol II (Fig. 6A, lane 2 ; Fig. 6B , lane 2, respectively). Additionally, assays that included the anti-gD antibody produced no interactions of the UL4 protein with TBP or Pol II from HeLa cells infected with EHV-1 (Fig. 6A, lane 3 ; Fig. 6B, lane 3, respectively) . However, when the anti-UL4P antibody was used to immunoprecipitate protein complexes from EHV-1 infected cells, interactions of the UL4 protein were observed with both TBP and Pol II (Fig. 6A, lane 4; Fig. 6B , lane 4, respectively). . GST-pulldown assays were completed to determine whether the UL4 protein directly interacts with general transcription factors. Purified GST, GST-IR2, or GST-UL4 fusion proteins were incubated with GST-Bind resin beads for 1.5 h before being combined with (A) TATA box-binding protein (TBP) or (B) RNA polymerase II carboxy-terminal domain (Pol II CTD) for an additional 1.5 h incubation. Captured proteins were eluted and resolved by SDS-PAGE and western blot using TBP or Pol II CTD specific antibodies. MW, molecular weight marker. . GST-pulldown assays were completed to determine whether the UL4 protein directly interacts with general transcription factor TFIIA or TFIIB or the EHV-1 IE protein. Purified GST (negative control), GST-TAD (positive control), GST-IE (positive control) or GST-UL4 fusion proteins were incubated with GST-Bind resin beads for 1.5 h before being combined with (A) TFIIA, (B) TFIIB, or (C) EHV-1 IE. Captured proteins were eluted and resolved by SDS-PAGE and western blot using anti-TFIIA antibody, anti-TFIIB antibody, or anti-IE specific antibody. MW, molecular weight marker. Details are in the "Materials and Methods" section.
To confirm these interactions of the UL4 protein with these two cell factors essential for transcription, reverse immunoprecipitation assays using antibody to TBP and antibody to Pol II CTD were carried out. Control reactions employed pre-immune serum or anti EHV-1 gD antibody. Precipitates were then probed with pre-immune serum or anti-UL4P antibody. As shown in Fig. 7A , precipitates obtained from EHV-1 infected cells with anti-TBP antibody revealed the presence of the UL4 protein. In contrast negative control precipitates of mock-infected cells or precipitates obtained by use of anti-gD antibody as the primary antibody failed to reveal the UL4 protein. Similarly, reverse precipitation assays using anti-Pol II CTD antibody as the primary antibody confirmed the interaction of the UL4 protein with Pol II CTD during EHV-1 infection (Fig. 7B) . The interaction of the UL4 protein with these cellular factors was demonstrated at both early (6 h) and late times (10 h and 16 h) after infection. Overall, findings from GSTpulldown assays and both series of immunoprecipitation analyses indicate that the interaction of the UL4 protein with the TBP and Pol II occurs during viral infection.
Late gene expression is augmented in the absence of the UL4 protein Our previous work (Charvat et al. 2011) and findings in Fig. 1 and Table 1 indicate that promoters representative of all three EHV-1 gene classes were inhibited by the expression of the UL4 protein. However, the effect of the UL4 protein on global viral gene expression was unknown. Therefore, the effect of the UL4 protein on the expression of all 78 EHV-1 genes was assessed via microarray analysis using cells that were either mock infected or infected with wild-type EHV-1 or ΔUL4 EHV-1. It was hypothesized that the greatest effect of UL4 protein expression would be evident for the regulatory genes of EHV-1. Unexpectedly, it was observed that the genes with the most enhanced expression in the absence of the UL4 protein were those of the late class responsible for mature virus particle assembly and maturation (Table 2A) . The included genes encode tegument proteins, capsid proteins, proteins involved in cleavage and packaging of nascent genomes, and glycoproteins. The only regulatory gene with significantly increased expression in the absence of the UL4 protein was the late ETIF gene that encodes a protein that localizes within the tegument and is necessary for secondary envelopment and egress of viral particles (von Einem et al., 2006) . The remaining regulatory genes of EHV-1 were considered to be unaffected in the absence of the UL4 protein (Table 2B) . As expected, no UL4 gene expression was observed in the ΔUL4 EHV-1 infected cells. These data suggest that during lytic infection, one role of the UL4 protein is to regulate the expression of late genes.
Viral DNA synthesis is not retarded in cells infected with ΔUL4 EHV-1
The microarray data indicated that the genes most affected in the absence of UL4 were those of the late class responsible for assembly and maturation of viral particles. However, these changes in viral gene expression did not significantly affect virus replication as the ΔUL4 EHV-1 and wild type EHV-1 replicated with similar kinetics during a 24-h time course (Fig. 8A) . Extensive quantitative PCR analyses revealed that viral DNA synthesis was not retarded in the absence of the UL4 protein, and cells infected with wild type and ΔUL4 EHV-1 produced similar amounts of viral DNA by 24 h post infection (Fig. 8B) .
Discussion
It was reported previously that transient expression of the EHV-1 UL4 protein inhibited expression from reporter genes that were under the control of a variety of promoters (Charvat et al., 2011) . Furthermore, in the absence of the UL4 protein during EHV-1 lytic infection, expression of representative transcripts of all three gene classes was increased. These observations suggested that the UL4 protein plays a role in regulating gene expression, but no insight into the mechanism of inhibition was provided. In this report, we demonstrate that expression of the UL4 protein is associated with a decrease in the level of reporter gene transcripts (Fig. 1) . However, the reduced transcript levels were not a result of increased mRNA instability or turnover (Table 1) . Taken together, these observations indicate that the UL4 protein-mediated inhibition of gene expression occurs at the level of transcription. However, the UL4 protein does not inhibit gene expression by binding to viral promoters as demonstrated by gel retardation and ChIP assays, which is in contrast to that demonstrated for the EHV-1 IR2 negative regulatory protein (Kim et al., 2006 (Kim et al., , 2011 . Protein-protein interactions with cellular transcription factors play a role in inhibiting viral gene expression in a number of viral systems. The human T-cell leukemia virus encodes a bZIP factor that interacts with transcription factor CREB-2 to regulate viral gene expression (Gaudray et al., 2002) . Protein interactions between the simian virus 40 (SV40) T antigen and AP-2 prevent AP-2 from binding to DNA to activate viral gene transcription (Mitchell et al., 1987) . During infection with high-risk human papillomaviruses, the viral E8\widehatE2C protein mediates repression of viral gene expression by interacting with cellular corepressor molecules, nuclear receptor corepressor 1 (NCoR1), and the chromodomain helicase DNA binding domain 6 protein (CHD6) (Ammermann et al., 2008; Fertey et al., 2010; Powell et al., 2010) . Therefore, it was hypothesized that the UL4 protein mediated its inhibitory activity during the process of transcription, presumably at the stage of pre-initiation complex (PIC) assembly and recruitment of the RNA polymerase. Indeed, protein-protein interaction assays revealed that the UL4 protein could directly bind to purified TATA box-binding protein (TBP) and the carboxy-terminal domain (CTD) of Pol II (Fig. 4) . Additionally, a series of co-immunoprecipitation analyses confirmed that the UL4 protein interacted with these two cellular factors in EHV-1 infected cells (Figs. 6 and 7) . Additional experiments showed that the UL4 protein did not directly associate with general transcription factors TFIIA or TFIIB or with the sole EHV-1 immediate early regulatory protein (Fig. 5) . The possibility that the UL4 protein could prevent TBP translocation into the nucleus, thus blocking the critical initiating step in PIC assembly was not substantiated by ongoing immunofluorescence assays to monitor TBP localization in the presence and absence of UL4 protein expression (data not shown). It remains unclear whether the direct interaction of the UL4 protein with TBP and Pol II diminishes their ability to interact with DNA. This question and the identification of domains within the UL4 protein responsible for its interaction with general transcription factors are the focus of future studies.
It has been well documented that the phosphorylation state of the CTD of Pol II is intimately involved in the progression of transcription from initiation and elongation to termination (Buratowski et al., 1989; Hirose and Ohkuma, 2007; Kobor and Greenblatt, 2002) . A potential mechanism for the UL4 protein-mediated inhibition of gene (Telford et al., 1992) .
expression may involve dysregulation of the dynamic process of CTD phosphorylation. The direct interaction of the UL4 protein with the CTD may prevent the association between the kinases and/or phosphatases that maintain the appropriate levels of phosphorylation to switch between initiation and elongation or elongation and termination. Likewise, the inhibitory activity may involve binding of the UL4 protein such that it directly eclipses the serines in the heptapeptide repeats that are the targets of phosphorylation (Hengartner et al., 1998; Komarnitsky et al., 2000; Ni et al., 2004) . Whether the UL4 protein alters the state of CTD phosphorylation is an interesting avenue of investigation and would represent a novel mechanism for EHV-1 gene regulation. That the majority of the EHV-1 genes with enhanced expression in the absence of the UL4 protein were those of the late gene class responsible for assembly and maturation of infectious viral particles was unexpected (Tables 2A and 2B ). Thus, during lytic infection, expression of the UL4 protein may prevent the late genes from being transcribed before DNA replication has completed. This could limit the exhaustion of the nucleotide pool and prevent translation of structural proteins that might assemble capsids before significant numbers of daughter genomes can be replicated, which would diminish the assembly of non-infectious empty particles. Additionally, the reduction of late gene expression may facilitate efficient DNA replication, due to the fact that the incoming viral genome would serve as the template for DNA replication as opposed to a template for late gene transcription. Despite these considerations, extensive quantitative PCR analyses clearly revealed that viral DNA synthesis is not retarded in the absence of the UL4 protein (Fig. 8B) . It is possible that the UL4 protein preferentially regulates late genes by preventing the association of the IE and UL5 proteins with general transcription factors, such as TBP, that were demonstrated to be critical for maximal EHV-1 late gene expression (Albrecht et al., 2004; Zhao et al., 1995) . Additional studies are focused on determining if the UL4 protein competes with the IE and UL5 proteins for binding to TBP.
Overall, these findings further demonstrate the inhibitory activity of the UL4 protein and suggest a mechanism by which the UL4 protein affects viral gene expression, namely its direct interactions with two cellular proteins essential for transcription. These interactions may be important for the inhibition of late gene expression as well as for efficient viral DNA replication. Future studies will address how the interactions between the UL4 protein and the transcription machinery contribute to the inhibition of EHV-1 gene expression and efficient viral replication. (Telford et al., 1992) . c ORF1 deleted in wild-type EHV-1 and ΔUL4 EHV-1. d ORF4 deleted in ΔUL4 EHV-1 but present in wild-type EHV-1.
Materials and methods
Cell culture and viruses
Mouse fibroblast L-M, rabbit kidney RK13, and human HeLa cells were grown in Dulbecco's minimum essential medium (DMEM) supplemented with 5% fetal bovine serum at 37 1C in a 5% CO 2 incubator. Wild-type, ΔUL4, and ΔUL4Res EHV-1 of the pathogenic RacL11 strain background were used for these studies (Charvat et al., 2012) .
Plasmids and transfection procedure
The luciferase reporter plasmids, the effector gene expression plasmids, and the GST fusion protein plasmids used in the transient transfection assays were generated elsewhere (Bowles et al., 2000; Charvat et al., 2011; Smith et al., 1992) . RK13 cells were transfected using lipofectin (Invitrogen, Carlsbad, CA) and Opti-MEM medium (Gibco, BRL, Carlsbad, CA) as described previously (Ahn et al., 2007) . One pmol of reporter plasmid and 0.5 pmol of effector plasmid were employed in most assays. Transfection efficiencies of 70% or greater were routinely obtained.
Luciferase and northern blot analysis
Two groups of RK13 cells were co-transfected with gK-Luc and either the EICP0 or UL4 protein expression plasmids. For one group of cells, luciferase activity was determined 48 h post-transfection utilizing the luciferase activity kit (Promega, Madison, WI) and the POLARstar OPTIMA plate reader (BMG LABTECH Inc., Cary, NC) per manufacturer's instructions (Ahn et al., 2007) . For the other group of cells, total RNA was isolated at 4 h post-transfection using the RNABee RNA isolation reagent (AMS Biotechnology (Europe) Ltd., Abingdon, UK). RNA samples were separated on a 6% denaturing ureapolyacrylamide gel and transferred onto a positively-charged nylon membrane (Ambion, Austin, TX) using a semi-dry electroblotter (BioRad Laboratories). Immobilized RNA was hybridized with a probe specific for the luciferase transcript (5′-GGTGTTGGAGCAAGATGGAT-3′). RNA levels were determined by densitometric measurement of the radiolabeled bands after exposure to a phosphor screen and scanning with the molecular imager FX system.
mRNA half-life
Rabbit kidney cells were infected with either wild-type EHV-1 or ΔUL4 EHV-1 at an MOI of 5. Twelve hours post-infection, the normal growth medium was replaced with growth medium supplemented with 1 μM Actinomycin D. Every 3 h, total RNA samples were collected for a total of 18 h. cDNA was synthesized from the RNA samples using the iScript™ cDNA Synthesis Kit per the manufacturer's specifications (Bio-Rad Laboratories). Transcript levels were determined by quantitative real-time PCR analysis using the iQ™ SYBR s Green Supermix (Bio-Rad Laboratories). The EHV-1 glycoprotein 2 (gp2, gene EUs4) transcript was detected with forward primer 5′-TACAACAACTGAGACTAC-3′ and reverse primer 5′-GGAGAACTGCTACTATTAG-3′, and the total transcript levels were normalized to cellular 28S rRNA using forward primer 5′-TATCATTGTGAAGCAGAA-3′ and reverse primer 5′-AACAACACATCATCAGTA-3′.
Electromobility shift assays
DNA binding assays were completed using IE, TK, IR4, and UL5 promoter DNA sequences along with GST, GST-IR2, or GST-UL4 fusion proteins. Promoter DNAs were radiolabeled with [α-32 P]-dATP and diluted in DNA-binding buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 10 mM β-mercaptoethanol, 0.1% CHAPS, 100 mM NaCl). Radiolabeled promoter DNAs were incubated with equivalent amounts of purified GST fusion proteins for 20 min at room temperature (Kim et al., 1995) . DNA-protein complexes were resolved on a 3.2% polyacrylamide gel and then dried onto Whatman chromatography paper (Whatman International Ltd., Maidstone, England). The chromatography paper was exposed to a phosphor screen and scanned with the molecular imager FX system.
Chromatin immunoprecipitation assays (ChIP)
HeLa cells were infected with EHV 1 RacL11 at a MOI of 10 and harvested at 6, 10, 12, and 16 h after infection. The cells were crosslinked with 1% formaldehyde for 10 min followed by adding 1 Â glycine for 5 min. After adding the Halt protease and phosphatase inhibitor cocktail (Pierce Biotechnology, Rockford, IL), the cells were scrapped and collected. The chromatin preparation was then processed according to the manufacturer's protocol (Pierce Biotechnology). Lysis buffer was added and micrococcal nuclease digestion was carried out for 15 min at 37 1C followed by centrifugation at 9000g for 5 min. Pre-immune serum, anti-UL4 antibody (Charvat et al., 2011) or anti CTD of Pol II antibody (Protein One, Bethesda, MD) was added in a spin column and incubated overnight at 4 1C. After washing, the elution process and DNA purification were carried out according to the manufacturer's protocol. PCR was performed to amplify the target DNA using appropriate primers: EHV 1 UL4 gene was amplified by the forward primers: 5′-CAT GGT ACC CCA ACG CAA ACA GTT GGC ACC GTG-3′, and reverse primers 5′-CAT AGA TCT CAG GCT GGG AAT TTG CTC GAC TGA AG-3′. The EHV 1 IE gene was amplified by the forward primers: 5′-ACG ACG ATG AGA TGG AGA TG-3′, and reverse primers 5′-ACA GCG ATA CCG AGA CCT G-3′. The EHV 1 TK gene was amplified by the forward primers: 5′-GAG CAC GAC TGG ACG AGT TA-3′, and reverse primers 5′-GTC CGC TTC AAA GAG AGT CC-3′. The EHV 1 gK gene was amplified by the forward primers: 5′-AAA GGT CCT GCT TAG AGC CA-3′, and reverse primers 5′-ACG AGT TCT TAT CGC CGA CT-3′. PCR products were analyzed in a BioRad XR imaging system. Pre-immune serum was employed as the negative control.
GST-pulldown assays
In vitro protein-protein interaction assays were described previously (Albrecht et al., 2004) . Briefly, 2 mg of purified GST, GST-IR2, or GST-UL4 protein was combined with 40 mL of a 50% mix of GST-Bind resin beads (Novagen, Madison, WI) in 650 mL NETN buffer (100 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl [pH 8.0], 0.5% NP-40) and incubated at room temperature for 1.5 h. One microgram of purified transcription factors TATA box-binding protein (TBP), Pol II CTD, TFIIA, or TFIIB (Protein One, Bethesda, MD) were added to the samples and incubated for an additional 1.5 h. The samples were centrifuged and washed five times with NETN buffer. Precipitated proteins were resolved by SDS-PAGE on 10% polyacrylamide gels and transferred to nitrocellulose membranes. Transcription factor protein complexes were detected with specific antibodies to TBP, Pol II CTD, TFIIA or TFIIB (Protein One). Antibody to the EHV-1 IE protein was described previously (Kim et al., 2003) .
Co-immunoprecipitation assays
Human HeLa cells were infected with wild-type RacL11 EHV-1 (MOI ¼10) and cellular lysates were prepared at 6, 10 and 16 h post-infection. The samples were diluted with a Tris-saline solution (10 mM Tris-HCl [pH 8.0] and 14 mM NaCl) and pre-cleared by mixing with 30 mL of a 50% mix of Protein-A agarose beads (Sigma, St. Louis, MO) for 2 h at room temperature. At the same time, 10 mL of the UL4 protein-specific antibody (Charvat et al., 2011) or a non-related anti-glycoprotein D (gD) specific antibody were complexed with a separate 30 mL of a 50% mix of Protein-A agarose beads. The beads were pelleted by centrifugation, and the pre-cleared samples were added to the antibody-bound beads and incubated for 2 h at room temperature. The beads were washed five times with 500 mL of the Tris-saline solution, and after the final wash, the beads were pelleted. SDS sample buffer was added, and the samples were boiled for 5 min before being resolved on 10% polyacrylamide gels. The precipitated protein complexes were detected with either the TBP or Pol II CTD specific antibodies (Protein One). Reverse immunoprecipitation assays using antibody to TBP and antibody to Pol II CTD were carried out by a similar procedure. Control reactions employed pre-immune serum or anti EHV-1 gD antibody. Precipitates were then probed with preimmune serum or anti-UL4P antibody. The input proteins, TBP and Pol II CTD, were obtained from Protein One.
Microarray analysis
RK13 cells were infected with wild-type or ΔUL4 EHV-1 (MOI ¼10) for 18 h before total RNA was isolated using the RNABee reagent. Double-stranded cDNA was synthesized using the primers for cellular GAPDH (forward: 5′-TGCCCCCATGTTTGTGATG-3′ reverse: 5′-TGTGGTCATGAGCCCTTC-3′) and the EHV-1 glycoprotein K (gK) gene (forward: 5′-AAAGGTCCTGCTTAGAGCCA-3′ reverse: 5′-ACGAGTTCTTATCGCCGACT-3′), and the EHV-1 gp2 gene primers (forward: 5′-TACAACAACTGAGACTAC-3′ reverse: 5′-GGAGAACTGCTACTATTAG-3′). Statistical analysis for the infectious titer results was completed using the mean of logtransformed data and a two way Student T test, and one way T test for the quantitation of viral genomic DNA.
